Form 8-K - Current report:
SEC Accession No. 0001193125-25-135864
Filing Date
2025-06-05
Accepted
2025-06-05 16:05:36
Documents
12
Period of Report
2025-06-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d924577d8k.htm   iXBRL 8-K 30506
  Complete submission text file 0001193125-25-135864.txt   148110

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA clym-20250604.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE clym-20250604_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clym-20250604_pre.xml EX-101.PRE 11701
14 EXTRACTED XBRL INSTANCE DOCUMENT d924577d8k_htm.xml XML 3766
Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 251027096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)